Thomson Reuters/Verus cut shares of Johnson & Johnson (NYSE:JNJ) from a hold rating to a sell rating in a research report sent to investors on Monday morning, AnalystRatingsNetwork.com reports.
Johnson & Johnson (NYSE:JNJ) opened at 89.93 on Monday. Johnson & Johnson has a 1-year low of $68.51 and a 1-year high of $94.42. The stock has a 50-day moving average of $87.78 and a 200-day moving average of $87.31. The company has a market cap of $253.4 billion and a price-to-earnings ratio of 19.96. Johnson & Johnson also was the target of unusually large options trading activity on Tuesday. Stock investors acquired 20,371 call options on the company. This is an increase of 145% compared to the typical volume of 8,310 call options.
Johnson & Johnson (NYSE:JNJ) last released its earnings data on Tuesday, October 15th. The company reported $1.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.32 by $0.04. The company had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $17.46 billion. During the same quarter in the previous year, the company posted $1.25 earnings per share. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. Analysts expect that Johnson & Johnson will post $5.46 EPS for the current fiscal year.
JNJ has been the subject of a number of other recent research reports. Analysts at Goldman Sachs Group Inc. upgraded shares of Johnson & Johnson from a sell rating to a neutral rating in a research note to investors on Friday, October 11th. They now have a $95.00 price target on the stock, up previously from $87.00. Separately, analysts at Zacks reiterated a neutral rating on shares of Johnson & Johnson in a research note to investors on Friday, August 30th. They now have a $91.00 price target on the stock. Finally, analysts at Argus raised their price target on shares of Johnson & Johnson from $8.00 to $104.00 in a research note to investors on Thursday, July 18th. They now have a buy rating on the stock. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of Hold and a consensus target price of $88.29.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.